DNA shed from colon cancers into bloodstream successfully guides chemotherapy after surgery
A multi-institutional, international study found that testing for ctDNA after surgery and directing chemotherapy to ctDNA-positive patients reduced the use of chemotherapy overall without compromising recurrence-free survival.
Materials provided by Johns Hopkins Medicine. Note: Content may be edited for style and length.
Source link aaaaa